Skip to main content

General Dermatology Derm Q&A

A recent study showed several inflammatory skin diseases, including atopic dermatitis, were associated with an increased risk for venous thromboembolism. In an interview with The Dermatologist, Jonathan Silverberg, MD, PhD, MPH, discussed these findings and their implications for clinical practice.
Melissa Weiss, Associate Editor
A recent survey suggested about 20% of patients were unsure of the meaning of one or more common dermatology terms. In an interview with The Dermatologist, lead study author Brett C. Neill, MD, at the University of Kansas Medical Center, discussed these findings and how dermatologists can better educate their patients.
Melissa Weiss, Associate Editor
Edward Ross, MD, presented the literature and latest results on the use of a non-thermal, ultra-short, high-voltage electric pulse device for treating cellular lesions, such as warts, seborrheic keratoses, and more.
Melissa Weiss, Associate Editor
Erosive lichen planus of the vulva that is recalcitrant to first-line topical therapy is extremely difficult to treat. In a recent research letter, Dr Cline et al investigated the use of methotrexate for this debilitating disease. She and Dr Pichardo, principal investigator, discussed these findings with The Dermatologist.
Melissa Weiss, Associate Editor
A recent study showed resolution and improvement in keloids on an African American patient with atopic dermatitis treated with dupilumab. Corresponding author, Emma Guttman, MD, discussed the implications of this finding with The Dermatologist.
Melissa Weiss, Associate Editor
Overprescription of opioids is a major contributor to the opioid epidemic. Justin M. McLawhorn, MD, and his colleagues developed guidelines published in JAAD for prescribing opioids following dermatologic procedures. He discussed the guidelines in an interview with The Dermatologist.
Melissa Weiss, Associate Editor
A recent study presented at the American Society of Plastic Surgeons 88th Annual Scientific Meeting showed an autologous homologous skin construct (AHSC) effectively closed complex wounds. Mark S. Granick, MD, discussed these findings further with The Dermatologist.
Melissa Weiss, Associate Editor
Results from a phase 2 study show promise for a new topical gene therapy for patients with dystrophic epidermolysis bullosa (DEB). Peter Marinvokich, MD, discusses the implications of this therapy for patients with DEB in an interview with The Dermatologist.
Back to Top